Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More
Health care industry
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Ro said it hopes its new tool will be able to help patients understand their GLP-1 coverage options so they
Read More
Your health records are coming to new apps. Here’s why
It's about to get a lot easier for patients in the U.S. to access their own medical records. Source link
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance
Read More
Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says
The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer's patients who take the therapy get
Read More
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion on increased demand for key products, particularly
Read More
Here are JPMorgan’s top drug stock picks into earnings
These are JPMorgan's top drug picks heading into earnings. Source link
Read More
These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but
Read More
Dexcom shares plunge more than 40%, head for worst day on record
Dexcom, which had its stock market debut in 2005, is headed for its worst day ever after lowering its full-year
Read More